Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.
about
Etanercept in the treatment of plaque psoriasisSelective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease.The safety of etanercept for the treatment of plaque psoriasis.B cell maintenance of subcapsular sinus macrophages protects against a fatal viral infection independent of adaptive immunityRole of lymphotoxins in the development of Peyer's patches and mesenteric lymph nodes: relevance to intestinal inflammation and treatment.Lymphotoxin-alpha plays only a minor role in host resistance to respiratory infection with virulent type A Francisella tularensis in mice.Alterations of splenic architecture in malaria are induced independently of Toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinityThe absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in miceEctopic lymphoid tissues and local immunity.Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense.Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: evidence of defective M-cell formation in vivo.Molecular Responses to the Zika Virus in Mosquitoes.Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
P2860
Q34620263-FBC504C1-305B-4277-AD85-AEC8643200AAQ35804422-EFA7DDDE-BC43-4F8A-B054-647528B4F9BCQ35919214-3013F727-08A7-428C-9D15-3A5F7D6A6BEAQ35984119-D77D96EA-9DC0-4A83-B590-48DA614EBFEBQ36631451-30FDBC0B-99C6-4A2D-BA23-D8B993170CD5Q36844371-885C58AD-DDF8-44BD-85F6-D42C9F94EF68Q36845116-A68BCC7B-B368-4045-9AD0-F81B4B01FDDFQ36845128-CE63EE26-166A-442C-9134-D1CD0879DE2AQ37075235-445A4697-4A1A-4157-A10C-A782D814D1D4Q38953303-C1D0CF7F-6169-4F03-A27D-2A1A1A8D58C4Q41445006-6AB7B8DD-234F-4919-8B3B-B2F03546709AQ54214336-2393AC6F-4D5E-4CE4-A08E-0C3B1598D3A4Q58781970-3E163F6B-6A0D-4BD0-8803-62EBD6E7FB41
P2860
Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@ast
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@en
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@nl
type
label
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@ast
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@en
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@nl
prefLabel
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@ast
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@en
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@nl
P2093
P2860
P1476
Role of lymphotoxin in experim ...... hotoxin-beta receptor pathway.
@en
P2093
Adriano Fontana
Hans-Pietro Eugster
Thomas W Spahn
Torsten Kucharzik
P2860
P304
P356
10.1128/IAI.73.11.7077-7088.2005
P407
P577
2005-11-01T00:00:00Z